169 related articles for article (PubMed ID: 17330240)
1. The amplified WWP1 gene is a potential molecular target in breast cancer.
Chen C; Zhou Z; Ross JS; Zhou W; Dong JT
Int J Cancer; 2007 Jul; 121(1):80-87. PubMed ID: 17330240
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer.
Chen C; Sun X; Guo P; Dong XY; Sethi P; Zhou W; Zhou Z; Petros J; Frierson HF; Vessella RL; Atfi A; Dong JT
Oncogene; 2007 Apr; 26(16):2386-94. PubMed ID: 17016436
[TBL] [Abstract][Full Text] [Related]
3. The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.
Zhou Z; Liu R; Chen C
Int J Cancer; 2012 Apr; 130(7):1504-10. PubMed ID: 21480222
[TBL] [Abstract][Full Text] [Related]
4. WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
Li Y; Zhou Z; Alimandi M; Chen C
Oncogene; 2009 Aug; 28(33):2948-58. PubMed ID: 19561640
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
Cheng Q; Cao X; Yuan F; Li G; Tong T
Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
[TBL] [Abstract][Full Text] [Related]
6. The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11.
Chen C; Zhou Z; Liu R; Li Y; Azmi PB; Seth AK
Oncogene; 2008 Nov; 27(54):6845-55. PubMed ID: 18724389
[TBL] [Abstract][Full Text] [Related]
7. WWP1 gene is a potential molecular target of human oral cancer.
Lin JH; Hsieh SC; Chen JN; Tsai MH; Chang CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):221-31. PubMed ID: 23849376
[TBL] [Abstract][Full Text] [Related]
8. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
[TBL] [Abstract][Full Text] [Related]
10. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
[TBL] [Abstract][Full Text] [Related]
11. Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator.
Nguyen Huu NS; Ryder WD; Zeps N; Flasza M; Chiu M; Hanby AM; Poulsom R; Clarke RB; Baron M
J Pathol; 2008 Sep; 216(1):93-102. PubMed ID: 18604872
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.
Subik K; Shu L; Wu C; Liang Q; Hicks D; Boyce B; Schiffhauer L; Chen D; Chen C; Tang P; Xing L
Bone; 2012 Apr; 50(4):813-23. PubMed ID: 22266093
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of WWP1 inhibits growth and invasion, but induces apoptosis of osteosarcoma cells.
Wu Z; Zan P; Li S; Liu J; Wang J; Chen D; Wang H; Qian Y; Luo L; Huang X
Int J Clin Exp Pathol; 2015; 8(7):7869-77. PubMed ID: 26339351
[TBL] [Abstract][Full Text] [Related]
14. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
15. WW domain-containing E3 ubiquitin protein ligase 1 depletion evokes antitumor effect in cutaneous squamous cell carcinoma by inhibiting signal transducer and activator of transcription 3 signaling pathway.
Xia Y; Chang X; Lian S; Zhu W
J Int Med Res; 2018 Jul; 46(7):2898-2912. PubMed ID: 29888632
[TBL] [Abstract][Full Text] [Related]
16. WWP1 E3 ligase at the crossroads of health and disease.
Behera A; Reddy ABM
Cell Death Dis; 2023 Dec; 14(12):853. PubMed ID: 38129384
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2.
Wang Z; Wang J; Li X; Xing L; Ding Y; Shi P; Zhang Y; Guo S; Shu X; Shan B
Int J Oncol; 2014 Oct; 45(4):1469-78. PubMed ID: 25051198
[TBL] [Abstract][Full Text] [Related]
18. WWP1 inactivation enhances efficacy of PI3K inhibitors while suppressing their toxicities in breast cancer models.
Kishikawa T; Higuchi H; Wang L; Panch N; Maymi V; Best S; Lee S; Notoya G; Toker A; Matesic LE; Wulf GM; Wei W; Otsuka M; Koike K; Clohessy JG; Lee YR; Pandolfi PP
J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907909
[TBL] [Abstract][Full Text] [Related]
19. The Evaluation of WBP2NL-Related Genes Expression in Breast Cancer.
Nourashrafeddin S; Aarabi M; Modarressi MH; Rahmati M; Nouri M
Pathol Oncol Res; 2015 Apr; 21(2):293-300. PubMed ID: 25417742
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
